Access cutting-edge cytomegalovirus infection treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access cytomegalovirus infection specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cytomegalovirus infection treatment provided free
CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) with refractory cytomegalovirus (CMV) infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ transplant. Funding Source: FDA OOPD
Sponsor: New York Medical College
Check if you qualify for this cytomegalovirus infection clinical trial in Baltimore, MD
If you're searching for cytomegalovirus infection treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cytomegalovirus infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.